144 related articles for article (PubMed ID: 1921448)
1. Inhibitory effect of norcantharidin on K562 human myeloid leukemia cells in vitro.
Yi SN; Wass J; Vincent P; Iland H
Leuk Res; 1991; 15(10):883-6. PubMed ID: 1921448
[TBL] [Abstract][Full Text] [Related]
2. Effects of norcantharidin, a protein phosphatase type-2A inhibitor, on the growth of normal and malignant haemopoietic cells.
Liu XH; Blazsek I; Comisso M; Legras S; Marion S; Quittet P; Anjo A; Wang GS; Misset JL
Eur J Cancer; 1995 Jun; 31A(6):953-63. PubMed ID: 7646929
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
[TBL] [Abstract][Full Text] [Related]
4. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
[TBL] [Abstract][Full Text] [Related]
5. The preliminary observation on immunosuppressive effect of norcantharidin in mice.
Yan MS; Xiue S; Wei LX; Piao XH
Immunopharmacol Immunotoxicol; 1993 Jan; 15(1):79-85. PubMed ID: 8450182
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of norcantharidin cytotoxic effects on oral cancer cells and normal buccal keratinocytes.
Kok SH; Hong CY; Kuo MY; Lee CH; Lee JJ; Lou IU; Lee MS; Hsiao M; Lin SK
Oral Oncol; 2003 Jan; 39(1):19-26. PubMed ID: 12457717
[TBL] [Abstract][Full Text] [Related]
7. Effect of norcantharidin on the human breast cancer Bcap-37 cells.
Liu D; Shi P; Yin X; Chen Z; Zhang X
Connect Tissue Res; 2012; 53(6):508-12. PubMed ID: 22606958
[TBL] [Abstract][Full Text] [Related]
8. Cross-resistance studies of folylpolyglutamate synthetase-deficient, methotrexate-resistant CCRF-CEM human leukemia sublines.
McGuire JJ; Heitzman KJ; Haile WH; Russell CA; McCloskey DE; Piper JR
Leukemia; 1993 Dec; 7(12):1996-2003. PubMed ID: 8255099
[TBL] [Abstract][Full Text] [Related]
9. Medical uses of mylabris in ancient China and recent studies.
Wang GS
J Ethnopharmacol; 1989 Sep; 26(2):147-62. PubMed ID: 2689797
[TBL] [Abstract][Full Text] [Related]
10. [Preparation of the immunotoxin 2E8-norcantharidin and its targeting killing effect in vitro].
Li LX; Tang YM; Zhang HZ; Shen HQ; Qian BQ; Luo CF
Zhonghua Er Ke Za Zhi; 2008 Jul; 46(7):493-7. PubMed ID: 19099803
[TBL] [Abstract][Full Text] [Related]
11. Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin.
Liu Q; Sun H; Li X; Sheng H; Zhu L
Molecules; 2022 Nov; 27(22):. PubMed ID: 36431851
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin blocks Wnt/β-catenin signaling via promoter demethylation of WIF-1 in glioma.
Xie D; Xie J; Wan Y; Ma L; Qi X; Wang K; Yang S
Oncol Rep; 2016 Apr; 35(4):2191-7. PubMed ID: 26781164
[TBL] [Abstract][Full Text] [Related]
13. [Studies on antitumor agents II: synthesis and anticancer activity of dehydrogenated carboncyclic analogs of norcantharidin].
Fang Y; Tian SL; Li KQ; Zhao SW; Wang ZY
Yao Xue Xue Bao; 1993; 28(12):931-5. PubMed ID: 8030418
[TBL] [Abstract][Full Text] [Related]
14. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
[TBL] [Abstract][Full Text] [Related]
15. Effect of norcantharidin on N-acetyltransferase activity in HepG2 cells.
Wu LT; Chung JG; Chen JC; Tsauer W
Am J Chin Med; 2001; 29(1):161-72. PubMed ID: 11321474
[TBL] [Abstract][Full Text] [Related]
16. Norcantharidin-induced post-G(2)/M apoptosis is dependent on wild-type p53 gene.
Hong CY; Huang SC; Lin SK; Lee JJ; Chueh LL; Lee CH; Lin JH; Hsiao M
Biochem Biophys Res Commun; 2000 Sep; 276(1):278-85. PubMed ID: 11006118
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells.
Lin CL; Chen CM; Lin CL; Cheng CW; Lee CH; Hsieh YH
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1867-1876. PubMed ID: 28760656
[TBL] [Abstract][Full Text] [Related]
18. Norcantharidin inhibits pre-replicative complexes assembly of HepG2 cells.
Chen S; Qu X; Wan P; Li QW; Wang Z; Guo F; Bai L; Hu Z; Tan W; Li J
Am J Chin Med; 2013; 41(3):665-82. PubMed ID: 23711148
[TBL] [Abstract][Full Text] [Related]
19. Norcantharidin induces cell cycle arrest and inhibits progression of human leukemic Jurkat T cells through mitogen-activated protein kinase-mediated regulation of interleukin-2 production.
Liao HF; Chen YJ; Chou CH; Wang FW; Kuo CD
Toxicol In Vitro; 2011 Feb; 25(1):206-12. PubMed ID: 21075198
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of norcantharidin against renal tubulointerstitial fibrosis.
Yun QS; Bao YX; Jiang JB; Guo Q
Pharmacol Rep; 2024 Apr; 76(2):263-272. PubMed ID: 38472637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
